Printer Friendly
In December, the House of Representatives will vote on OTC derivatives reform and broader financial reform. Tabb Group Senior Analyst Kevin McPartland discusses these and other deadlines as well as the challenges that must be overcome in the House and Senate for the financial reform to move forward.
Like this article? Sign up for Wall Street & Technology's daily e-mail newsletter to get more news and analysis delivered right to your in-box.
